Peter (Heungil) Oh, Ph.D.
*** ******** ***** **. *, Pittsburgh, PA 15237
********@*****.*** c: 412-***-****
Fermentation / Bioprocess Scientist
Biotechnology Biopharmaceuticals Fermentation
Detail-oriented, highly skilled researcher, proficient in use of
fermentation technologies and methodologies with experience in process
optimization and scale-up. Familiarity with strain development, bioassays,
and fermentation / downstream processes (chromatography, membrane
filtration, crystallization, etc.). Proven success leading and serving as
integral contributing member in multidisciplinary teams. Talent for clearly
articulating technical information in easily understandable terms.
Expertise includes:
Strain Development / Bioassays / Process Analysis & Optimization
Scale-up Design / Column Chromatography / Technical Documentation
Educational Background
Korea University, Seoul, South Korea
Ph.D. in Bioengineering
Professional Experience
Post-Doctoral Research Associate
University of Pittsburgh - Pittsburgh, PA
Serve as key scientist for various assay-based projects with responsibility
for managing laboratories, developing protocol, and drafting reports and
presentations. Train graduate students and summer interns in proper
laboratory procedures. Key project includes "Early Detection Point-of-Care
Testing Device for Prognosis of Sepsis".
Graduate Student Researcher
Korea University - Seoul, South Korea
< Development of Immuno-Chromatographic Assay System for Peptic Ulcer
Disease
. Optimized cultivation conditions for large-scale culture of
Helicobacter pylori.
. Designed and developed purification steps to obtain specific
antigens from the microorganism utilizing column chromatography
(ion exchange and size exclusion), PAGE, Western blotting,
dialysis, and ultrafiltration.
Scientist
Yuhan Chemical - Ansan, South Korea
Recruited to R&D activities for developing process of secondary metabolites
production via microbial fermentation. Selected Achievements:
< Developed improved strains: Natural / UV selection.
< Designed and implemented bioreactor experiments at bench top (3-7 L)
and pilot scale (1500 L).
< Optimized downstream procedures and processes.
< Assisted in transferring fermentation and purification processes to
manufacturing scale.
< Commercialized Tobramycin and Cyclosporin A for the first time in South
Korea.